Literature DB >> 9762667

Monocyte activation in multiple sclerosis.

A T Reder1, K Genç, P V Byskosh, A M Porrini.   

Abstract

Monocytes, macrophages, and microglia have a central role in the CNS inflammation of MS. Monocytes are important in the earliest events in MS. Peripheral blood monocytes secrete prostaglandins before MS attacks. During clinical activity monocyte activation markers increase and IL-1 and TNF-alpha levels are elevated. Other monocyte products such as IL-10 reduce inflammation. IL-10 mRNA in MNC is increased during stable disease. Manipulation of monokine secretion and expression of monocyte surface proteins are reasonable approaches for immune therapy of MS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9762667     DOI: 10.1177/135245859800400314

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  9 in total

1.  Glatiramer acetate treatment normalized the monocyte activation profile in MS patients to that of healthy controls.

Authors:  Delgertsetseg Chuluundorj; Scott A Harding; David Abernethy; Anne Camille La Flamme
Journal:  Immunol Cell Biol       Date:  2016-10-03       Impact factor: 5.126

2.  Discovery of novel disease-specific and membrane-associated candidate markers in a mouse model of multiple sclerosis.

Authors:  Laura F Dagley; Nathan P Croft; Ruth Isserlin; Jonathan B Olsen; Vincent Fong; Andrew Emili; Anthony W Purcell
Journal:  Mol Cell Proteomics       Date:  2013-12-20       Impact factor: 5.911

3.  Reduced inflammation accompanies diminished myelin damage and repair in the NG2 null mouse spinal cord.

Authors:  Karolina Kucharova; Yunchao Chang; Andrej Boor; Voon Wee Yong; William B Stallcup
Journal:  J Neuroinflammation       Date:  2011-11-13       Impact factor: 8.322

4.  Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder.

Authors:  Byung Soo Kong; Yeseul Kim; Ga Young Kim; Jae-Won Hyun; Su-Hyun Kim; Aeran Jeong; Ho Jin Kim
Journal:  J Neuroinflammation       Date:  2017-09-25       Impact factor: 8.322

Review 5.  The Roles of Monocyte and Monocyte-Derived Macrophages in Common Brain Disorders.

Authors:  Mingxia Zhao; Houzhen Tuo; Shuhui Wang; Lin Zhao
Journal:  Biomed Res Int       Date:  2020-06-04       Impact factor: 3.411

Review 6.  Albumin and multiple sclerosis.

Authors:  Steven M LeVine
Journal:  BMC Neurol       Date:  2016-04-12       Impact factor: 2.474

7.  Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction.

Authors:  Gijs Kooij; Claudio Derada Troletti; Alessandro Leuti; Paul C Norris; Ian Riley; Maria Albanese; Serena Ruggieri; Stephania Libreros; Susanne M A van der Pol; Bert van Het Hof; Yoëlle Schell; Gisella Guerrera; Fabio Buttari; Nicola Biagio Mercuri; Diego Centonze; Claudio Gasperini; Luca Battistini; Helga E de Vries; Charles N Serhan; Valerio Chiurchiù
Journal:  Haematologica       Date:  2019-11-28       Impact factor: 9.941

8.  Immunological Subsets Characterization in Newly Diagnosed Relapsing-Remitting Multiple Sclerosis.

Authors:  Emanuele D'Amico; Aurora Zanghì; Nunziatina Laura Parrinello; Alessandra Romano; Giuseppe Alberto Palumbo; Clara Grazia Chisari; Simona Toscano; Francesco Di Raimondo; Mario Zappia; Francesco Patti
Journal:  Front Immunol       Date:  2022-02-22       Impact factor: 7.561

9.  Expansion of Neutrophils and Classical and Nonclassical Monocytes as a Hallmark in Relapsing-Remitting Multiple Sclerosis.

Authors:  David Haschka; Piotr Tymoszuk; Gabriel Bsteh; Verena Petzer; Klaus Berek; Igor Theurl; Thomas Berger; Günter Weiss
Journal:  Front Immunol       Date:  2020-04-29       Impact factor: 8.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.